OmniPleat(R) Filter Media Sets New Standard for Dust Collector Replacement Filters

Jonesboro, Arkansas, Oct. 27, 2025 (GLOBE NEWSWIRE) — Camfil Air Pollution Control (APC) introduces its proprietary OmniPleat(R) media technology engineered to extend filter life and improve performance compared to conventional pleated filters. OmniPleat filter media is available for premium filter cartridges for all brands of dust collectors and is offered in a variety of media […]

Cizzle Bio CEO Bill Behnke Moderates High-Profile Panel on Value-Based Cancer Diagnostics at 2025 AVBCC Summit

Cizzle Bio Inc. founder and CEO Bill Behnke moderated a high-profile panel at the 2025 Association for Value-Based Cancer Care (AVBCC) Summit, held Oct. 22-24 in New York City. The session, titled “Advancing Cancer Diagnostics to Commercialization: Bridging Innovation, Access, and Value,” convened leading experts in oncology diagnostics, reimbursement, and digital health to explore how

Toronto Pearson announces innovation pilots with DMZ, Creative Destruction Lab

Toronto Pearson is announcing new innovation pilot programs with technology incubator DMZ and global startup program Creative Destruction Lab. The two pilot programs, both set to run for six months, are meant to broaden the airport's pool of suppliers beyond traditional aviation technology companies, said Brian Tossan, Toronto Pearson's chief technology officer and interim chief

OmniPleat(R) Filter Media Sets New Standard for Dust Collector Replacement Filters

OmniPleat(R) Filter Media Sets New Standard for Dust Collector Replacement Filters Camfil Air Pollution Control (APC) introduces its proprietary OmniPleat(R) media technology available for premium filter cartridges for all brands of dust collectors. GlobeNewswire October 27, 2025 Jonesboro, Arkansas, Oct. 27, 2025 (GLOBE NEWSWIRE) — Camfil Air Pollution Control (APC) introduces its proprietary OmniPleat(R) media

ISPE Names CSL Behring the 2025 ISPE Facility of the Year Awards (FOYA) Overall Winner for its Project Aurora Plasma Base Fractionation Facility (Facility F)

CSL Behring has been honored with this prestigious award recognizing innovation and excellence in pharmaceutical facility projects, as the FOYA program celebrates its 20th anniversary The International Society for Pharmaceutical Engineering (ISPE) has recognized CSL Behring as the Overall Winner of the 2025 ISPE Facility of the Year Awards (FOYA) for itsProject Aurora Plasma Base

InventHelp Inventor Develops New Accessory for Inflatable Decorations (TLS-927)

“I thought there should be an attractive way to conceal holiday lawn inflatables during the day when not in use,” said an inventor, from Tarpon Springs, Fla., “so I invented the INFLATE – AWAY. My design prevents the yard from being littered with uninflated, limp figures that may detract from the home's appearance.” https://mma.prnewswire.com/media/2099578/InventHelp_Logo_jpg_Logo.jpg The

Lilly declares fourth-quarter 2025 dividend

The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2025 of $1.50 per share on outstanding common stock. The dividend is payable on December 10, 2025, to shareholders of record at the close of business on November 14, 2025. About Lilly Lilly is a

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in VF Corporation of Class Action Lawsuit and Upcoming Deadlines – VFC

NEW YORK CITY, NY / ACCESS Newswire / October 27, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against VF Corporation ("VFC" or the "Company") (NYSE:VFC).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Fortinet, Inc. of Class Action Lawsuit and Upcoming Deadlines – FTNT

NEW YORK CITY, NY / ACCESS Newswire / October 27, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Fortinet, Inc. ("Fortinet" or the "Company") (NASDAQ:FTNT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines – CYTK

NEW YORK CITY, NY / ACCESS Newswire / October 27, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate ("Cytokinetics" or the "Company") (NASDAQ:CYTK).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Scroll to Top